Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline Plus Amiodarone for the Prevention of Postoperative Atrial Fibrillation
NCT01422148Phase 2Withdrawn
- Sponsor
- Baystate Medical Center
- Start
- Sep 2025
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of minocycline in Atrial fibrillation (AFib) (2 arms), sponsored by Baystate Medical Center. Primary endpoint: Postoperative Atrial Fibrillation at 6 weeks. Planned start Sep 2025; status: withdrawn.
02
Drugs
minocycline
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT01422148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01422148.